Anne Seidlitz studied pharmacy in Greifswald and obtained her license as a pharmacist in 2003. From 2003 to 2005 she worked as a team member and later on team leader in the galenics department of the Arzneimittel Werke Altona AG in Hamburg. Afterwards she returned to Greifswald University in and received a Doctor of Natural Sciences in Pharmaceutical Technology in 2009. In 2015 she was granted the degree of a habilitated Doctor in the Natural Sciences. Furthermore she was the qualified person according to the German Medicinal Products Act at the hospital pharmacy of the University Medicine Greifswald. After positions as substitute professor at the University of Hamburg and the Friedrich Schiller University Jena she was appointed full professor of Pharmaceutics and Biopharmaceutics at the Heinrich Heine University Düsseldorf in 2021. Anne Seidlitz has accepted the appointment by the Free University Berlin for the full professorship in pharmaceutical technology starting at October 2024. Her main research areas are dosage form development with a focus on solid dosage forms and biorelevant dissolution testing of parenteral non-oral dosage forms. She is active participatn in different pharmaceutical organisations such as the International Association for Pharmaceutical Technology (Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik, APV), the EUFEPS Network On Bioavailability And Biopharmaceutics and the scientific council of the German Federal Chamber of Pharmacists (Bundesapothekerkammer).

Current research areas of the Seidlitz group

• Biorelevant release testing
  • Using tissue simulating hydrogel compartments
  • Simulating physiological flow and / or movement
  • Using 3D-printing technologies to develop new / adapted apparatuses
  • Currently for implants and injections such as intravitreal dosage forms, dosage forms for intramuscular and subcutaneous delivery, etc.
  • Development of dosage forms using extrusion and 3D-printing
    • Production of drug-containing filaments for fdm-based printing
    • Printing of implants and oral dosage forms via fdm and sse
    • Characterization of the printed dosage forms
    • Individualization
    • Influencing drug release